Posted Jul. 14, 2017 at 12:29 p.m.

Premium Lock Raleigh-based biotech seeks orphan drug status for ulcerative colitis therapy

Published: 2017-07-14 12:29:29
Updated: 2017-07-14 12:29:29

New drugs New drugs Image 1 of 2 · Next Image…

Innovate Biopharmaceuticals, a clinical-stage biotechnology company based in Raleigh, has submitted an application to the U.S. Food and Drug Administration seeking orphan drug designation for an oral therapy to treat pediatric ulcerative colitis....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders